Newsflash

Welcome To
Middle Country Family Medicine Website
.


We Hope You Find
The Website Useful

Flu Season is Upon Us....
Don't forget to schedule an
appointment for a flu shot.

A federal panel recommended Wednesday that all children get an annual flu shot, dramatically expanding the pool of people who are urged to ward off the contagious respiratory illness -- and possibly paving the way for a universal flu shot recommendation.

The Advisory Committee on Immunization Practices, which makes recommendations to the Centers for Disease Control and Prevention, expanded the group of children who should get annual flu shots to include healthy children ages 5-18. Previously, the recommendation included only those 6 months to age 5.

 

Bookmark Us

 
 

Contact Information

Dr. Michael Randall
2539 Middle Country Road

Centereach, New York 11720
Tel:  (631)580-1740
Fax:  (631)580-9155

:: Contact Us ::
:: Directions ::


Plan route with GMaps

Plan your route to us


Visitors Counter

mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter

Home arrow Medical News
Medical News
MedWorm: Swine Flu
MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest headlines from journals and sites in the Swine Flu category.





Related Items

Medical News Updates


Clinical Trials / Drug Trials News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

Road-Map Agreed For Confirmatory Trials Of Promising Microbicide
Two further clinical trials are planned to confirm a vaginal gel which has shown potential in reducing the risk of HIV. The results of the first trial of the gel, which were announced in July at the XVIII International AIDS Conference in Vienna, must be confirmed before the product can be made available for general use...

Gynecologic Cancer Patients Should Consider Clinical Trials
For the estimated 83,000 women who will be diagnosed with a gynecologic cancer in 2010, participation in clinical trials offers an opportunity both to ensure that future patients benefit from the most up-to-date treatments and increased survival rates and to potentially improve the health of current patients...

Successful Completion Of First Clinical Trials On Potent New Hepatitis C Drug
The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed...

Depression Significantly Improved By Non-Invasive Therapy
Major depression is a common and disabling brain condition marked not only by the presence of depressed mood but also by its effects on sleep, energy, decision-making, memory and thoughts of death or of suicide. Major depression affects 15 million adults in the U.S...

Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia
Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tablets will be registered in Australia under the trade name Movectro®...

HeartWare Receives Second Patient Allotment Under Continued Access Protocol For Pivotal U.S. Bridge-To-Transplant Clinical Trial
HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S...

Optimer Pharmaceuticals Announces Presentations Of Additional Fidaxomicin Phase 3 Data At Upcoming ICAAC Annual Meeting
Results from studies related to Optimer Pharmaceuticals, Inc.'s (Nasdaq: OPTR) lead developmental product candidate, fidaxomicin, will be presented at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) to be held at the Boston Convention and Exhibition Center in Boston on September 12-15, 2010...

Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At World Pain Congress In Montreal, Canada
Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced the final data set from its Phase 3 study of Ketotransdel® (TDLP-110) at the 13th World Congress on Pain in Montreal, Canada...

Insurance Providers

medicare.jpg
bluecrossblushield.gif
aetna.jpg
hip.jpg

For a Complete List
Click Here


© 2010 Middle Country Family Medicine
Joomla! is Free Software released under the GNU/GPL License.